TCR-T
-
Shocking! Genentech is set to close its cancer immunology research department, and star scientists are resigning
Welcome friends to leave a message in the comments section!
-
Stock prices soar by 220%! CGT, once “unsellable,” is back in the spotlight
If you are intersted in TCR-T, you are welcome to watch DrugTimes webinar tonight
